Alternatives to Ivabradine If You Can't Fill Your Prescription

Ivabradine (Corlanor) is a one-of-a-kind heart failure medication — it's the only drug in its class approved by the FDA for reducing hospitalizations in heart failure patients with reduced ejection fraction. But what happens if you can't access it? Whether it's a supply issue at your pharmacy, an insurance denial, or cost concerns, this guide explains the alternatives your doctor might consider — and what you should know about each one.

Important: Talk to Your Doctor Before Making Any Changes

Ivabradine has a unique mechanism of action — it slows heart rate without affecting blood pressure or heart contractility. No other drug does exactly what it does. Any switch should be made in consultation with your cardiologist or heart failure specialist, who can assess your specific clinical situation. Do not stop Ivabradine without medical guidance.

Why Ivabradine Is Used in the First Place

Ivabradine is specifically indicated for adults with heart failure with reduced ejection fraction (HFrEF) — an LVEF of 35% or less — who have a resting heart rate of at least 70 bpm while already on the maximum tolerated dose of a beta-blocker, or who cannot take beta-blockers at all. Its job is to reduce heart rate further, which takes stress off the failing heart and reduces the chance of hospitalization.

Alternative 1: Optimized Beta-Blocker Therapy

If you're on Ivabradine because your heart rate wasn't controlled enough on a beta-blocker, the first question your cardiologist will ask is: "Is this patient truly at the maximum tolerated beta-blocker dose?"

Guideline-directed beta-blockers for HFrEF include:

Carvedilol (Coreg): Target dose 25-50 mg twice daily. Non-selective beta-blocker with alpha-blocking activity. Widely available as a generic, typically very affordable.

Metoprolol succinate (Toprol-XL): Target dose 200 mg once daily. Extended-release beta-1 selective blocker. Generic is widely available and inexpensive.

Bisoprolol: Target dose 10 mg once daily. Highly selective beta-1 blocker. Used widely in Europe and available in the US.

These beta-blockers are proven to reduce mortality in HFrEF. If Ivabradine is unavailable, your cardiologist may try to optimize your beta-blocker dose as a first step.

Alternative 2: Digoxin (Lanoxin)

Digoxin is a cardiac glycoside that can reduce heart rate and improve symptoms in heart failure. While it doesn't reduce mortality, it can reduce hospitalizations. It's been used for heart failure for decades and is widely available as an inexpensive generic.

Key caveats: Digoxin has a narrow therapeutic window (easy to take too much), requires regular blood level monitoring, and has many drug interactions. It's not suitable for everyone. Your cardiologist will decide if it makes sense for your situation.

Alternative 3: Sacubitril/Valsartan (Entresto)

Entresto (sacubitril/valsartan) is not a heart rate–lowering drug, but it's an important guideline-directed therapy for HFrEF that reduces mortality and hospitalizations. If you're on Ivabradine but not yet on Entresto, your cardiologist may prioritize adding Entresto to your regimen.

Entresto works differently from Ivabradine — it's an angiotensin receptor-neprilysin inhibitor (ARNI) that reduces neurohormonal activation. It's often used alongside Ivabradine, not as a direct replacement, but it can improve overall heart failure outcomes.

Alternative 4: SGLT2 Inhibitors (Jardiance, Farxiga)

Empagliflozin (Jardiance) and dapagliflozin (Farxiga) are SGLT2 inhibitors that were originally developed for type 2 diabetes but have been shown to reduce heart failure hospitalizations and cardiovascular death in patients with HFrEF. These are now part of guideline-directed therapy for all HFrEF patients.

Like Entresto, SGLT2 inhibitors are not a direct Ivabradine replacement (they don't primarily lower heart rate), but they are important complementary therapies. If you're not yet on one, your cardiologist may use this gap as an opportunity to optimize your overall HFrEF regimen.

What's NOT a Reasonable Substitution for Ivabradine

Some medications should not be used as a straight substitution for Ivabradine without careful evaluation:

Calcium channel blockers (verapamil, diltiazem): These can slow heart rate but are generally avoided in HFrEF due to negative inotropic effects. In fact, these drugs can interact dangerously with Ivabradine if used together.

Amiodarone: Has heart rate–slowing effects but is generally used for arrhythmias, not routine HR management in HFrEF. Also has significant toxicity concerns.

What to Ask Your Cardiologist If You Can't Get Ivabradine

"Should we try increasing my beta-blocker dose to manage my heart rate?"

"Is digoxin appropriate for my situation?"

"Am I on all the guideline-directed therapies I should be for HFrEF?"

"Can you help me find a pharmacy that has Ivabradine in stock, or are there patient assistance programs I can use?"

The Bottom Line

Ivabradine is unique in what it does, and there's no perfect drop-in replacement. However, your cardiologist has several tools available to optimize your heart failure care if Ivabradine is temporarily unavailable. Before accepting that you simply can't get it, make sure you've explored all ways to locate it — including using medfinder to search pharmacies near you.